Acute Effects of the 5‐Hydroxytryptamine Type 4 Receptor Agonist Mosapride on Pharyngeal Swallowing Physiology in Adults
The Kaohsiung Journal of Medical Sciences · 2025
DOI: 10.1002/kjm2.70125 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift The Kaohsiung Journal of Medical Sciences, 2025. Verfasst von Shu-Wei Liang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan. Hauptthemen laut MEDLINE: Benzamides, Morpholines, Deglutition, Serotonin 5-HT4 Receptor Agonists. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation.
Abstract (Originalsprache)
The 5‐hydroxytryptamine type 4 receptor agonist mosapride is known to modulate esophageal peristalsis and enhance lower esophageal sphincter compliance. However, its impact on oropharyngeal swallowing physiology remains insufficiently characterized. This study aimed to investigate the acute effects of mosapride on oropharyngeal swallowing dynamics in adults. Participants received either oral mosapride (40 mg) or placebo 1 h prior to testing in a randomized, crossover design. High‐resolution impedance manometry was performed using a solid‐state catheter to measure pressure and impedance within the oropharyngeal segment. Each participant underwent at least three swallows of 5, 10, and 20 mL thin and thick liquids administered by syringe. Manometric data were analyzed using the Swallow Gateway web‐based platform. Twenty‐four volunteers (13 male, mean age, 33 years; range, 24–56 years) completed the study. During thick swallows, mosapride significantly increased upper esophageal sphincter (UES) maximal opening admittance compared to placebo (5 mL: p = 0.017; 10 mL: p = 0.008) and reduced UES integrated relaxation pressure (10 mL: p = 0.018; 20 mL: p = 0.017). No significant effects were observed during thin liquid swallows. A marginal reduction in pre‐deglutitive UES basal pressure was noted during 5 mL thick swallows ( p = 0.050). Following adjustment using repeated measures ANOVA, only the reduction in UES basal pressure remained statistically significant ( p = 0.040). Acute administration of oral mosapride results in reduced UES basal tone in adults. These findings provide novel physiological evidence suggesting that mosapride may modulate neuroregulatory mechanisms controlling UES contractility.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Gastroenterology and Hepatology, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan.
- Department of Medicine, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation and Tzu Chi University, Hualien, Taiwan.
- Flinders Health and Medical Research Institute, Flinders University, Adelaide, Australia.
- Institute of Medical Sciences, Tzu Chi University, Hualien, Taiwan.
ORCID-Profile: Shu-Wei Liang, Chien-Lin Chen
Förderung
- Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
Zitieren
APA
Liang, S. W., Hung, J. S., Omari, T., Wong, M. W., Lei, W. Y., Liu, T. T., Yi, C. H., & Chen, C. L. (2025). Acute Effects of the 5‐Hydroxytryptamine Type 4 Receptor Agonist Mosapride on Pharyngeal Swallowing Physiology in Adults. The Kaohsiung Journal of Medical Sciences. https://doi.org/10.1002/kjm2.70125
Vancouver
Liang SW, Hung JS, Omari T, Wong MW, Lei WY, Liu TT, et al. Acute Effects of the 5‐Hydroxytryptamine Type 4 Receptor Agonist Mosapride on Pharyngeal Swallowing Physiology in Adults. The Kaohsiung Journal of Medical Sciences. 2025. doi:10.1002/kjm2.70125
BibTeX
@article{Liang2025,
author = {Liang, Shu-Wei and Hung, Jui-Sheng and Omari, Taher and Wong, Ming-Wun and Lei, Wei-Yi and Liu, Tso-Tsai and Yi, Chih-Hsun and Chen, Chien-Lin},
title = {Acute Effects of the 5‐Hydroxytryptamine Type 4 Receptor Agonist Mosapride on Pharyngeal Swallowing Physiology in Adults},
journal = {The Kaohsiung Journal of Medical Sciences},
year = {2025},
doi = {10.1002/kjm2.70125}
}
EUVIMED